Lexington diagnostics maker T2 Biosystems is pairing up with the U.S. government to develop tests that could identify biological threats like anthrax — a deal that could alleviate some of the struggling device company’s financial concerns.

Boston Biz Journal https://www.bizjournals.com/boston/news/2019/09/11/shares-of-t2-biosystems-rise-on-federal-contract.html?ana=RSS&s=article_search